SLC5A2 and diabetes mellitus: The potential mechanisms of SGLT2 inhibitors in DM or CV disease have been studied, Combined with the results of the overlay visualization of cooccurring author keywords and the burst keywords, the application of SGLT2 inhibitors on cardiac diastolic dysfunction and, especially, on the HFpEF was the newly evident research direction.